A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
Clinical trial NCT00170937 · COMPLETED
Trial details
- NCT number
- NCT00170937
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-11-01
- Primary completion
- 2006-03-01
- Enrollment
- 507
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.